The case for Novo Nordisk. Right now Novo Nordisk has a considerable lead on Lilly in GLP-1 market share, and a couple of ...

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies ...

Eli Lilly (LLY) has partnered with the government of the United Kingdom to see if its blockbuster weight loss drug could help ...

The UK government starts a trial offering weight loss drug Mounjaro to unemployed obese individuals to improve health and ...

Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take popular weight-loss and diabetes drugs off of the national shortage list, which will allow compounding ...

In a bid to combat obesity and unemployment, the UK govt is collaborating with Eli Lilly, which will invest £279 mn in a ...

The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...

Streeting announced a collaboration with the world's largest pharmaceutical company, Lilly, which will include a five-year ...

The new trial aims to gather evidence of the effects of the drug tirzepatide – sold by pharmaceutical company Lily under brand name Mounjaro ...

The UK Government is considering using weight-loss drugs to help support obese people in returning to work and reduce the high rates of long-term sickness, which have become a significant strain on ...

The U.K. will study whether Lilly's weight loss drug can get people back to work and help tackle long-term sickness ...

In response to the rapid increase in the number of adults taking a weight loss drug - an estimated 18 million adults - health ...